Methods for assessment, e.g., anthropometric indicators and imaging techniques, of several phenotypes of human obesity, with special reference to abdominal fat content, have been evaluated. The correlation of fat distribution with age, gender, total body fat, energy balance, adipose tissue lipoprotein lipase and lipolytic activity, adipose tissue receptors, and genetic characteristics are discussed. Several secreted or expressed factors in the adipocyte are evaluated in the context of fat tissue localization. The body fat distribution and the metabolic profile in nonobese and obese individuals is discussed relative to lipolysis, antilypolysis and lipogenesis, insulin sensitivity, and glucose, lipid, and protein metabolism. Finally, the endocrine regulation of abdominal visceral fat in comparison with the adipose tissue localized in other areas is presented.

/pdf/subcutaneous-and-visceral-adipose-tissue-their-relation-to-5crse4rslq.pdf

Subcutaneous and visceral adipose tissue : Their relation to the metabolic syndrome

Lifestyle modification helps in the primary prevention of diabetes in multiethnic American, Finnish and Chinese populations. In a prospective community-based study, we tested whether the progression to diabetes could be influenced by interventions in native Asian Indians with IGT who were younger, leaner and more insulin resistant than the above populations. We randomised 531 (421 men 110 women) subjects with IGT (mean age 45.9±5.7 years, BMI 25.8±3.5 kg/m2) into four groups. Group 1 was the control, Group 2 was given advice on lifestyle modification (LSM), Group 3 was treated with metformin (MET) and Group 4 was given LSM plus MET. The primary outcome measure was type 2 diabetes as diagnosed using World Health Organization criteria. The median follow-up period was 30 months, and the 3-year cumulative incidences of diabetes were 55.0%, 39.3%, 40.5% and 39.5% in Groups 1–4, respectively. The relative risk reduction was 28.5% with LSM (95% CI 20.5–37.3, p=0.018), 26.4% with MET (95% CI 19.1–35.1, p=0.029) and 28.2% with LSM + MET (95% CI 20.3–37.0, p=0.022), as compared with the control group. The number needed to treat to prevent one incident case of diabetes was 6.4 for LSM, 6.9 for MET and 6.5 for LSM + MET. Progression of IGT to diabetes is high in native Asian Indians. Both LSM and MET significantly reduced the incidence of diabetes in Asian Indians with IGT; there was no added benefit from combining them.

/pdf/the-indian-diabetes-prevention-programme-shows-that-54jk5f7o50.pdf

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)

The National Cholesterol Education Program’s Adult Treatment Panel III (ATP III) report [1] added the metabolic syndrome, a multidimensional risk factor for cardiovascular disease (CVD), as a coequal partner of elevated low-density lipoprotein (LDL) cholesterol for risk-reduction therapies. Interest in the metabolic syndrome has increased greatly since the publication of the ATP III report. There are several aspects to the metabolic syndrome that deserve consideration for clinical practice: 1) major clinical outcomes, 2) metabolic components, 3) pathogenesis, 4) clinical criteria for diagnosis, 5) risk for clinical outcomes, and 6) therapeutic interventions.

https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(05)66378-7.pdf

The Metabolic Syndrome

The metabolic syndrome is a multiplex risk factor that consists of several risk correlates of metabolic origin. In addition, to dyslipidemia, hypertension, and hyperglycermia, the syndrome carries a prothrombotic state and a proinflammatory state. Persons with the metabolic syndrome are at essentially twice the risk for cardiovascular disease compared with those without the syndrome. It further raises the risk for type 2 diabetes by about 5-fold. Although some investigators favor keeping risk factors separate for purposes of clinical management, others believe that identifying individuals with an aggregation of risk factors provides additional useful information to guide clinical management. In particular it focuses attention on obesity and sedentary life habits that are the root of the syndrome. This review addresses the prevalence of this clustering phenomenon throughout the world. Such seems appropriate because of the increasing prevalence of obesity in almost all countries. The available evidence indicates that in most countries between 20% and 30% of the adult population can be characterized as having the metabolic syndrome. In some populations or segments of the population, the prevalence is even higher. On the other hand, in parts of developing world in which young adults predominate, the prevalence is lower; but with increasing affluence and aging of the population, the prevalence undoubtedly with rise.

Metabolic Syndrome Pandemic

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure

Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria.

OBJECTIVE To study the prevalence of cardiovascular risk factors in native urban Asian Indians and to look for the occurrence of clustering of these factors. RESEARCH DESIGN AND METHODS The study included 953 subjects (532 men and 421 women), aged ≥ 40 years, selected from a population survey for diabetes, which was conducted in 1994 in Madras, Tamil Nadu, India. Measurements of anthropometry, blood pressure, plasma lipid profile, glucose tolerance, plasma insulin response, and electrocardiogram were made. Based on the normal ranges derived from the population study, abnormalities in anthropometric values, plasma lipids, and insulin values were determined. Age-adjusted prevalences of the abnormalities were calculated using data from a 1991 urban census in Madras. The expected prevalences of the abnormalities in isolation and in combinations were calculated and compared with the corresponding observed figures. RESULTS The prevalences of risk factors were in the order of central adiposity > dyslipidemia > hyperinsulinemia (2-h) > glucose intolerance > obesity > hypertension. The age-adjusted prevalence of coronary heart disease (CHD) was 3.9% (3.5% in men and 4.5% in women, NS), and T wave inversion was seen in an additional 10.3%. Isolated prevalences of all factors, except hypertension, were in lower frequency than expected. Combinations of each risk factor with one or two more risk factors occurred more frequently (1.3–4 times) than expected by chance. Impaired glucose tolerance and dyslipidemia showed association with hyperinsulinemia, whereas hypertension did not show such an association. CONCLUSIONS Clustering of the cardiovascular risk factors or the components of insulin resistance syndrome occurs in the native Asian Indian population. This finding under-scores the need for preventive aspects of metabolic disorders and CHD.

Clustering of Cardiovascular Risk Factors in Urban Asian Indians

OBJECTIVE —Due to a background of high prevalence of type 2 diabetes and the increasing rate of obesity occurring in relatively young urban children, we felt the need to look for type 2 diabetes in children.

RESEARCH DESIGN AND METHODS —A study of cases of type 2 diabetes with age at diagnosis of ≤15 years seen at a diabetes speciality center in Chennai, India, is reported. A total of 18 children (5 boys and 13 girls) aged 9–15 years with insidious onset of diabetes responding to oral antidiabetic agents (ODAs) for periods from 2 months to 12 years were studied. Clinical details, anthropometry, and details of family history of diabetes were elicited. All of them were tested for the presence of anti-GAD65 antibodies and for pancreatic β-cell reserve by measuring serum C-peptide response (radioimmunoassay procedures).

RESULTS —All children showed a response to ODAs, had good β-cell reserve (≥0.6 pmol/ml on stimulation), and negligible GAD65 antibodies indicating the presence of type 2 diabetes. The children were nonketotic; nine were obese, four had acanthosis nigricans, and one had polycystic ovary syndrome. Positive family history of diabetes was present in all cases.

CONCLUSIONS —The clinical, immunological, and biochemical profile showed that the children had type 2 diabetes. The profile of type 2 diabetes was similar to that described in children in many other countries. Although less common than type 1 diabetes, type 2 diabetes in children is a condition that needs to be recognized and looked for in Asian-Indians.

https://care.diabetesjournals.org/content/diacare/26/4/1022.full.pdf

Type 2 Diabetes in Asian-Indian Urban Children

Objective a) To determine the prevalence of microvascular and macrovascular complications in Type 2 diabetes in India and b) to identify the major factors for the complications. Methods A study was done in 3010 subjects (M:F 1892:1118, Mean age 52 +/- 9.7 years) attending a diabetic clinic. The study sample resembled the population sample in anthropometry, age and socioeconomic factors. All patients had undergone the tests for retinopathy, nephropathy, neuropathy, peripheral vascular disease (PVD) and cardiovascular disease by ECG. Results Retinopathy was diagnosed in 23.7% (background retinopathy in 20.0% and proliferative in 3.7%), proteinuria was present in 19.7% and persistant proteinuria of > or = 500 mg/dl was seen in 5.5% of them, CHD was present in 11.4% and PVD was present in 4.0%. Of the total 119 cases with PVD, 18 had gangrene and 21 had undergone amputations. Peripheral neuropathy was present in 27.5%. Cerebrovascular accidents were reported in 26 cases (0.9%). Hypertension was present in 38% of the cases. Multiple logistic regression analyses showed that age had a significant association with retinopathy, neuropathy, CHD and PVD. Duration of diabetes had significant association with the complications other than CHD. Higher HbA1 increased the risk of retinopathy, neuropathy and nephropathy. Hypertension was associated with the complications except PVD and neuropathy. The strongest association was between hypertension and nephropathy. Conclusion The study highlights the high prevalence of vascular complications in Type 2 diabetes in India. Retinopathy and neuropathy were the commonest complications of diabetes.

Prevalence of vascular complications and their risk factors in type 2 diabetes.

Aim To assess the effect of diabetes on tuberculosis (TB) treatment outcome and sputum conversion among new smear-positive (NSP) cases registered under Directly Observed Treatment Short Course in South India. Methods Details on sputum conversion and TB treatment outcome were collected from case records of NSP cases ( N =332; M/F 247:85) registered at TB units of three districts in Tamil Nadu. Subjects were screened for diabetes and categorized as diabetic (TBDM) ( n =96; 73:23) and non-diabetic (TBnonDM) ( n =149; 109:40). Results Among 245 selected TB patients, 93.5% were cured, 1.6% completed TB treatment, 2% had TB treatment failure (TF), and 0.4% had treatment default (TD), 0.4% with MDR-TB and 2% death rate. At the end of intensive phase of TB treatment, 14.7% remained sputum positive in the TBDM group, whereas it was 3.5% in the TBnonDM group. Mean duration (days) for sputum conversion was higher in the TBDM group (64.2±10.5) compared to the TBnonDM group (61.5±7.5) ( p Conclusions Delayed sputum conversion and high TB treatment failure rates were common in NSP cases with diabetes.

K. Satyavani

Papers

Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria.

Clustering of Cardiovascular Risk Factors in Urban Asian Indians

Type 2 Diabetes in Asian-Indian Urban Children

Prevalence of vascular complications and their risk factors in type 2 diabetes.

Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis— A report from South India☆